siRNA, Anti-SLC7A11, 2'-F/2'-OMe/2'-MOE/LNA/Ribo/Backbone-modified(CAT#: SIRGT41106WQ-2OMe)

The product SIRGT41106WQ-2OMe is a type of small interfering RNA (siRNA) that targets SLC7A11 gene and regulates the expression of gene. The siRNA interferes with the expression of SLC7A11 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2ʹ-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
NCBI RefSeq NM_014331.3
Alternative Names CCBR1; xCT
Related Diseases Kaposi Sarcoma and Cystinuria
Purification HPLC
Target Gene
Gene ID 23657
Uniprot ID Q9UPY5
Sub Cat Target Species Modification Scale  
SIRGT42106WQ-2F SLC7A11 Human 2ʹ-deoxy-2ʹ-fluoro (2'-F) Inquiry
SIRGT43106WQ-2MOE SLC7A11 Human 2'-O-methoxyethyl (2'-MOE) Inquiry
SIRGT44106WQ-LNA SLC7A11 Human Locked Nucleic Acid (LNA) Inquiry
SIRGT41106WQ-RB SLC7A11 Human Ribo-modified Inquiry
SIRGT42106WQ-BB SLC7A11 Human Backbone-modified Inquiry

Related Products